59
Views
1
CrossRef citations to date
0
Altmetric
Review

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

&
Pages 275-282 | Published online: 19 Oct 2022

References

  • BoonenSDelmasPDWenderothDH2006Risedronate shown to be safe and effective in men with osteoporosis in a 2-year, double-blind, randomized, placebo-controlled, multicentre studyOsteoporos Int17S23031
  • CohenSLevyRMKellerM1999Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group studyArthritis Rheum4223091810555025
  • DiamondTH2005Pharmacotherapy of osteoporosis in menExpert Opin Pharmacother6455815709882
  • HarrisSTWattsNBGenantHK1999Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study GroupJAMA28213445210527181
  • HawkesWGWehrenLOrwigD2006Gender differences in functioning after hip fractureJ Gerontol A Biol Sci Med Sci614959916720747
  • HendersonSHoffmanNPrinceR2006A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel diseaseAm J Gastroenterol1011192316405543
  • JiangHXMajumdarSRDickDA2005Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fracturesJ Bone Miner Res2049450015746995
  • KanajiAHigashiMNamisatoM2006Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosyLepr Rev771475316895071
  • LookerACOrwollESJohnstonCCJr1997Prevalence of low femoral bone density in older U.S. adults from NHANES IIIJ Bone Miner Res121761689383679
  • McClungMRGeusensPMillerPDEffect of risedronate on the risk of hip fracture in elderly women. Hip intervention program study groupN Engl J Med3443334011172164
  • MajimaTKomatsuYDoiK2006Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves’ diseaseJ Bone Miner Metab241051316502116
  • MeltonLJIIIAtkinsonEJO’ConnorMK1998Bone density and fracture risk in menJ Bone Miner Res131915239844110
  • MilgromCFinestoneANovackV2004The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruitsBone354182415268892
  • PoorGAtkinsonEJLewallenDG1995aAge-related hip fractures in men: clinical spectrum and short-term outcomesOsteoporos Int5419268695962
  • PoorGAtkinsonEJO’FallonWM1995bDeterminants of reduced survival following hip fractures in menClin Orthop Relat Res26065
  • ReginsterJMinneHWSorensenOH2000Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) Study GroupOsteoporos Int11839110663363
  • ReidDMAdamiSDevogelaerJP2001Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapyCalcif Tissue Int692424711730260
  • ReidDMHughesRALaanRF2000Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European corticosteroid-induced osteoporosis treatment studyJ Bone Miner Res1510061310841169
  • RingeJD2003[Osteoporosis in men]Dtsch Med Wochenschr1289252812715292
  • RingeJDFaberHFarahmandP2006Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year studyRheumatol Int264273116001181
  • SatoYIwamotoJKanokoT2005Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after strokeArch Intern Med16517434816087822
  • SawkaAMAdachiJDPapaioannouA2004Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?J Rheumatol3119939515468365
  • TauchmanovaLSelleriCEspositoM2003Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignanciesOsteoporos Int1410131914517597
  • TenenhouseAJosephLKreigerN2000Estimation of the prevalence of low bone density in canadian women and men using a population-specific DXA reference standard: the canadian multicentre osteoporosis study (CaMos)Osteoporos Int1189790411199195
  • VanderschuerenDBoonenSBouillonR2000Osteoporosis and osteoporotic fractures in men: a clinical perspectiveBaillieres Best Pract Res Clin Endocrinol Metab1429931511035908